<p>Cresco Labs Inc.（OTCMKTS:CRLBF - 获取免费报告）在周三的交易中创下了 52 周的新高。该股最高交易价格为 1.99 美元，最后交易价格为 1.93 美元，成交量为 910976 股。该股此前收盘价为 1.7541 美元。</p>
<h2>分析师评级调整</h2>
<p>多家研究公司最近对 CRLBF 进行了评估。ATB Capital 在 12 月 2 日的报告中将 Cresco Labs 的评级上调至 “跑赢大盘”。Atb Cap Markets 在 12 月 2 日的研究报告中将 Cresco Labs 的评级从 “持有” 上调至 “强力买入”。最后，Zacks Research 在 11 月 12 日的研究报告中将 Cresco Labs 的评级从 “强烈卖出” 上调至 “持有”。一位分析师给予该股 “强力买入” 评级，一位给予 “买入” 评级，一位给予 “持有” 评级。根据 MarketBeat 的数据，该公司的共识评级为 “买入”。</p>
<p><strong>查看我们关于 CRLBF 的最新股票报告</strong></p>
<h2>Cresco Labs 股票表现</h2>
<p>该公司的债务股本比率为 1.28，流动比率为 2.49，速动比率为 1.54。该股的 50 日移动平均价格为 1.06 美元，200 日移动平均价格为 0.93 美元。该公司的市值为 6.6915 亿美元，市盈率为-12.53，贝塔值为 1.55。</p>
<p>Cresco Labs（OTCMKTS:CRLBF - 获取免费报告）最近于 11 月 7 日发布了季度财报。该公司报告季度每股收益（EPS）为-0.05 美元，低于分析师的共识预期-0.03 美元，差额为-0.02 美元。Cresco Labs 的股本回报率为-14.25%，净利润率为-7.79%。该季度的营业收入为 1.65 亿美元，而共识预期为 1.6374 亿美元。股票分析师预计 Cresco Labs Inc.在当前年度将发布-0.2 美元的每股收益。</p>
<h2>关于 Cresco Labs</h2>
<p>（获取免费报告）</p>
<p>Cresco Labs Inc 及其子公司在美国从事零售和医疗大麻产品的种植、制造和销售。它提供以 Cresco 品牌销售的花朵、大麻蒸汽笔、活性树脂、一次性笔和提取物；以 High Supply 品牌销售的蒸汽罐、蒸汽笔、花朵、爆米花、摇晃、预卷、短卷和浓缩物；以 Good News 品牌销售的蒸汽和软糖；以 Wonder Wellness Co 品牌销售的蒸汽和食品；以及以 Remedi 品牌销售的酊剂、胶囊、药膏和舌下油。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票比 Cresco Labs 更好</li>
<li>每股收益计算器：如何计算 EPS</li>
<li>工业领域的大规模突破：现在必须关注的三只股票</li>
<li>什么是股息挑战者？</li>
<li>三只科技股下跌超过 60%——哪一只值得购买？</li>
<li>投资者需要知道的以战胜市场的信息</li>
<li>25 年后，思科终于从互联网泡沫崩溃中恢复过来</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Cresco Labs 吗？</h2>
<p>在考虑 Cresco Labs 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Cresco Labs 并不在名单上。</p>
<p>虽然 Cresco Labs 目前在分析师中获得 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

CRLBF

<p>Cresco Labs（OTCMKTS:CRLBF）达到了新的 52 周高点，交易价格高达 1.99 美元。分析师们对该股票进行了升级，ATB Capital 和 Atb Cap Markets 分别给予了 “跑赢大盘” 和 “强力买入” 的评级。尽管每股收益为负且股本回报率不佳，该公司在本季度报告了 1.65 亿美元的收入。Cresco Labs 的共识评级为 “买入”，但顶级分析师建议其他股票可能是更好的投资选择</p>

<p>Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report) hit a new 52-week high during trading on Wednesday . The stock traded as high as $1.99 and last traded at $1.93, with a volume of 910976 shares. The stock had previously closed at $1.7541.</p>
<div class="lb-trans"><p>Cresco Labs Inc.（OTCMKTS:CRLBF - 获取免费报告）在周三的交易中创下了 52 周的新高。该股最高交易价格为 1.99 美元，最后交易价格为 1.93 美元，成交量为 910976 股。该股此前收盘价为 1.7541 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级调整</h2>
</div><p>A number of research firms recently weighed in on CRLBF. ATB Capital raised Cresco Labs to an &#34;outperform&#34; rating in a report on Tuesday, December 2nd. Atb Cap Markets upgraded shares of Cresco Labs from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Tuesday, December 2nd. Finally, Zacks Research upgraded shares of Cresco Labs from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Wednesday, November 12th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of &#34;Buy&#34;.</p>
<div class="lb-trans"><p>多家研究公司最近对 CRLBF 进行了评估。ATB Capital 在 12 月 2 日的报告中将 Cresco Labs 的评级上调至 “跑赢大盘”。Atb Cap Markets 在 12 月 2 日的研究报告中将 Cresco Labs 的评级从 “持有” 上调至 “强力买入”。最后，Zacks Research 在 11 月 12 日的研究报告中将 Cresco Labs 的评级从 “强烈卖出” 上调至 “持有”。一位分析师给予该股 “强力买入” 评级，一位给予 “买入” 评级，一位给予 “持有” 评级。根据 MarketBeat 的数据，该公司的共识评级为 “买入”。</p>
</div><p><strong>View Our Latest Stock Report on CRLBF</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 CRLBF 的最新股票报告</strong></p>
</div><h2>Cresco Labs Stock Performance</h2>
<div class="lb-trans"><h2>Cresco Labs 股票表现</h2>
</div><p>The company has a debt-to-equity ratio of 1.28, a current ratio of 2.49 and a quick ratio of 1.54. The stock's 50-day moving average price is $1.06 and its 200-day moving average price is $0.93. The company has a market cap of $669.15 million, a P/E ratio of -12.53 and a beta of 1.55.</p>
<div class="lb-trans"><p>该公司的债务股本比率为 1.28，流动比率为 2.49，速动比率为 1.54。该股的 50 日移动平均价格为 1.06 美元，200 日移动平均价格为 0.93 美元。该公司的市值为 6.6915 亿美元，市盈率为-12.53，贝塔值为 1.55。</p>
</div><p>Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last released its quarterly earnings results on Friday, November 7th. The company reported ($0.05) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.02). Cresco Labs had a negative return on equity of 14.25% and a negative net margin of 7.79%.The business had revenue of $165.00 million for the quarter, compared to the consensus estimate of $163.74 million. Equities analysts anticipate that Cresco Labs Inc. will post -0.2 EPS for the current year.</p>
<div class="lb-trans"><p>Cresco Labs（OTCMKTS:CRLBF - 获取免费报告）最近于 11 月 7 日发布了季度财报。该公司报告季度每股收益（EPS）为-0.05 美元，低于分析师的共识预期-0.03 美元，差额为-0.02 美元。Cresco Labs 的股本回报率为-14.25%，净利润率为-7.79%。该季度的营业收入为 1.65 亿美元，而共识预期为 1.6374 亿美元。股票分析师预计 Cresco Labs Inc.在当前年度将发布-0.2 美元的每股收益。</p>
</div><h2>About Cresco Labs</h2>
<div class="lb-trans"><h2>关于 Cresco Labs</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.</p>
<div class="lb-trans"><p>Cresco Labs Inc 及其子公司在美国从事零售和医疗大麻产品的种植、制造和销售。它提供以 Cresco 品牌销售的花朵、大麻蒸汽笔、活性树脂、一次性笔和提取物；以 High Supply 品牌销售的蒸汽罐、蒸汽笔、花朵、爆米花、摇晃、预卷、短卷和浓缩物；以 Good News 品牌销售的蒸汽和软糖；以 Wonder Wellness Co 品牌销售的蒸汽和食品；以及以 Remedi 品牌销售的酊剂、胶囊、药膏和舌下油。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Cresco Labs</li>
<li>Earnings Per Share Calculator: How to Calculate EPS</li>
<li>Massive Breakout in Industrials: 3 Must-Watch Stocks Now</li>
<li>What Are Dividend Challengers?</li>
<li>3 Tech Stocks Down Over 60%—Which One Is Worth Buying?</li>
<li>What Investors Need to Know to Beat the Market</li>
<li>25 Years Later, Cisco Finally Recovers From the Dot-Com Crash</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Cresco Labs 更好</li>
<li>每股收益计算器：如何计算 EPS</li>
<li>工业领域的大规模突破：现在必须关注的三只股票</li>
<li>什么是股息挑战者？</li>
<li>三只科技股下跌超过 60%——哪一只值得购买？</li>
<li>投资者需要知道的以战胜市场的信息</li>
<li>25 年后，思科终于从互联网泡沫崩溃中恢复过来</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cresco Labs Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Cresco Labs 吗？</h2>
</div><p>Before you consider Cresco Labs, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Cresco Labs 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Cresco Labs 并不在名单上。</p>
</div><p>While Cresco Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Cresco Labs 目前在分析师中获得 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Cresco Labs (OTCMKTS:CRLBF) 创下 52 周新高 - 现在是买入的好时机吗？